H Finel
Overview
Explore the profile of H Finel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
248
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gutierrez-Garcia G, Martinez C, Boumendil A, Finel H, Malladi R, Afanasyev B, et al.
Br J Haematol
. 2021 Nov;
196(4):1018-1030.
PMID: 34750806
We analysed long-term outcome of patients receiving haematopoietic allogeneic stem cell transplantation (allo-HSCT) as a first transplant for high-risk Hodgkin lymphoma (HL). One hundred and ninety patients were included in...
2.
Domingo-Domenech E, Duarte R, Boumedil A, Onida F, Gabriel I, Finel H, et al.
Bone Marrow Transplant
. 2021 Jan;
56(6):1391-1401.
PMID: 33420392
Background: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative treatment option in advanced-stage mycosis fungoides (MF) and Sézary syndrome (SS). This study presents an updated analysis of the...
3.
Domingo-Domenech E, Boumendil A, Climent F, Sengeloev H, Wahlin B, Wattad W, et al.
Bone Marrow Transplant
. 2019 Nov;
55(4):796-803.
PMID: 31695174
Systemic anaplastic large cell lymphoma (sALCL) is a rare histological entity expressing the CD30 antigen that comprises around 11% of peripheral T-cell lymphoma. We analysed the outcome of patients with...
4.
Domingo-Domenech E, Boumendil A, Climent F, Socie G, Kroschinsky F, Finel H, et al.
Bone Marrow Transplant
. 2019 Nov;
55(3):633-640.
PMID: 31695173
Information regarding the curative role of allogeneic stem cell transplantation (allo-HCT) in systemic anaplastic large cell lymphoma (sALCL) is scarce. We analyzed the results of allo-HCT in patients with relapsed/refractory...
5.
Gonzalez-Barca E, Boumendil A, Blaise D, Trneny M, Masszi T, Finel H, et al.
Bone Marrow Transplant
. 2019 Sep;
55(2):393-399.
PMID: 31541205
Autologous hematopoietic stem cell transplantation (auto-HSCT) is the standard of care for patients with diffuse large B-cell lymphoma (DLBCL) who relapse/progress after first line chemoimmunotherapy. Long-term outcome of those who...
6.
Bento L, Boumendil A, Finel H, Le Gouill S, Amorim S, Monjanel H, et al.
Bone Marrow Transplant
. 2017 May;
52(8):1120-1125.
PMID: 28530668
Relapse remains the most common cause of treatment failure in patients receiving autologous stem cell transplantation (ASCT) for follicular lymphoma (FL). The aim of this study was to evaluate the...
7.
Genadieva-Stavrik S, Boumendil A, Dreger P, Peggs K, Briones J, Corradini P, et al.
Ann Oncol
. 2016 Dec;
27(12):2251-2257.
PMID: 28007754
Background: To evaluate long-term outcome of myeloablative allogeneic stem cell transplantation (allo-SCT) (MAC) versus reduced-intensity allo-SCT (RIC) in patients with relapsed/refractory Hodgkin's lymphoma (HL) in recent years. Patients And Methods:...
8.
Meissner J, Finel H, Dietrich S, Boumendil A, Kanfer E, Laboure G, et al.
Bone Marrow Transplant
. 2016 Dec;
52(4):650-652.
PMID: 27991887
No abstract available.
9.
Dietrich S, Finel H, Martinez C, Tischer J, Blaise D, Chevallier P, et al.
Leukemia
. 2016 May;
30(10):2086-2089.
PMID: 27146790
No abstract available.
10.
Robinson S, Boumendil A, Finel H, Schouten H, Ehninger G, Maertens J, et al.
Ann Oncol
. 2016 Mar;
27(6):1088-1094.
PMID: 26961149
Background: Patients with follicular lymphoma (FL) relapsing after an autologous transplant (autoSCT) may be treated with a variety of therapies, including a reduced intensity allogeneic transplant (RICalloSCT). We conducted a...